We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The parallel use of human challenge trials and large-scale conventional trials could help accelerate the development of an effective vaccine for COVID-19, NIH vaccine experts say. Read More
Sanofi and Regeneron Pharmaceuticals have stopped a phase 3 clinical trial in the U.S. of their rheumatoid arthritis drug Kevzara (sarilumab) as a COVID-19 treatment after it failed to meet its primary endpoints. Read More
Drugmakers have continued to hike their drug prices during the COVID-19 crisis, increasing prices on average 23.8 percent for 245 drugs, many of which are used in COVID-19 treatments or research. Read More
At least five drug developers working on COVID-19 therapeutics and vaccines with U.S. government funding have contracts that bypass laws that ensure taxpayer-funded drugs and vaccines are affordable, a new report says. Read More
Japanese drugmaker Fujifilm is partnering with India’s Dr. Reddy’s and Dubai-based Global Response Aid (GRA) to manufacture and sell its influenza drug Avigan (favipiravir) for the treatment of COVID-19. Read More
Bharat Biotech has received approval to begin clinical trials in India of its COVID-19 vaccine candidate. The trial will be the first for a COVID vaccine developed in that country. Read More
RSS
